(1)
NUR’AMIN, H. W.; Dwiprahasto, I.; Kristin, E. EFFECTIVENESS OF TICAGRELOR COMPARED TO CLOPIDOGREL IN REDUCING THE RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY HEART DISEASE AFTER PERCUTANEOUS CORONARY INTERVENTION. Int J Pharm Pharm Sci 2017, 9, 178-183.